Irlanda - inglês - HPRA (Health Products Regulatory Authority)

venus pharma gmbh - meropenem - powder for solution for injection/infusion - 500 milligram(s) - carbapenems; meropenem

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

noridem enterprises limited - meropenem - powder for solution for injection/infusion - 1 gram(s) - carbapenems; meropenem

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

hikma farmacêutica (portugal) s.a. - meropenem - powder for solution for injection/infusion - 500 milligram(s) - carbapenems; meropenem

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

venus pharma gmbh - meropenem trihydrate - powder for solution for injection/infusion - 1 gram(s) - carbapenems; meropenem

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

noridem enterprises limited - meropenem - powder for solution for injection/infusion - 500 milligram(s) - carbapenems; meropenem

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

hikma farmacêutica (portugal) s.a. - meropenem - powder for solution for injection/infusion - 1 gram(s) - carbapenems; meropenem

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - meropenem trihydrate, quantity: 570 mg (equivalent: meropenem, qty 500 mg) - injection, powder for - excipient ingredients: sodium carbonate - meropenem ranbaxy is indicated for the treatment of the following infections, in adults and children (aged 3 months and over), when the causative organisms are known or suspected to be resistant to commonly used antibiotics: - community acquired lower respiratory tract infection, - hospital acquired lower respiratory tract infection, - complicated urinary tract infection, - febrile neutropenia, - intra-abdominal and gynaecological (polymicrobial) infections, - complicated skin and skin structure infections, - meningitis, - septicaemia.

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - meropenem trihydrate, quantity: 1140 mg (equivalent: meropenem, qty 1 g) - injection, powder for - excipient ingredients: sodium carbonate - meropenem ranbaxy is indicated for the treatment of the following infections, in adults and children (aged 3 months and over), when the causative organisms are known or suspected to be resistant to commonly used antibiotics: - community acquired lower respiratory tract infection, - hospital acquired lower respiratory tract infection, - complicated urinary tract infection, - febrile neutropenia, - intra-abdominal and gynaecological (polymicrobial) infections,- complicated skin and skin structure infections, - meningitis, - septicaemia.

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

acino ag - meropenem trihydrate - powder for solution for injection/infusion - 500 milligram(s) - carbapenems; meropenem

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

acino ag - meropenem trihydrate - powder for solution for injection/infusion - 1 gram(s) - carbapenems; meropenem